XOMA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 10:14):

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health...

Stats
Today's Volume	2 674.00
Average Volume	18 772.00
Market Cap	291.58M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $-0.640 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.21
ATR14	$0.198 (0.79%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-08	Hughes Owen	Buy	275 000	Performance Stock Units
2023-10-03	Sitko Bradley	Buy	250	Common Stock
2023-10-02	Sitko Bradley	Buy	1 500	Common Stock
2023-10-02	Hughes Owen	Buy	1 000	Common Stock
2023-09-26	Hughes Owen	Buy	2 499	Common Stock

INSIDER POWER
96.85
Last 95 transactions
Buy: 1 668 857 \| Sell: 210 377

XOMA Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

XOMA Corp Financials

Annual	2023
Revenue:	$4.76M
Gross Profit:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2023
Revenue:	$4.76M
Gross Profit:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2022
Revenue:	$6.03M
Gross Profit:	$5.93M (98.39 %)
EPS:	$-1.500

FY	2021
Revenue:	$38.16M
Gross Profit:	$0.00 (0.00 %)
EPS:	$0.690

Financial Reports:

No articles found.

XOMA Corp

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.